Loading…

The effects of acute and chronic oral L-arginine supplementation on exercise-induced ammonia accumulation and exercise performance in healthy young men: A randomised, double-blind, cross-over, placebo-controlled trial

This study examined the effects of a single and chronic oral intake of l-arginine supplementation on blood ammonia concentration and exercise performance. Sixteen healthy young men (mean ± standard deviation, 23 ± 3 years) participated in a randomised, double-blind, cross-over, placebo-controlled st...

Full description

Saved in:
Bibliographic Details
Published in:Journal of exercise science and fitness 2022-04, Vol.20 (2), p.140-147
Main Authors: Hiratsu, Ayano, Tataka, Yusei, Namura, Saki, Nagayama, Chihiro, Hamada, Yuka, Miyashita, Masashi
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:This study examined the effects of a single and chronic oral intake of l-arginine supplementation on blood ammonia concentration and exercise performance. Sixteen healthy young men (mean ± standard deviation, 23 ± 3 years) participated in a randomised, double-blind, cross-over, placebo-controlled study. For the acute trials, the participants consumed 200 mL of water containing either l-arginine (5 g) or placebo (dextrin; 5.5 g) and performed cycling exercise at 75% of heart rate reserve for 60 min, followed by a 15-min cycling performance test. For the chronic trials, the participants continued to consume each designated supplement twice a day for another 13 days, and then repeated the same protocol as the acute trials at day 15. After a 14-day washout period, the participants changed the supplement and repeated the same protocol as above. Plasma ammonia concentrations were lower in the chronic arginine trial than those in both acute placebo (mean difference - 4.5 μmol/L) and acute arginine (mean difference - 5.1 μmol/L) trials (p 
ISSN:1728-869X
2226-5104
DOI:10.1016/j.jesf.2022.02.003